Application 214323
- Type
- ANDA
- Sponsor
- GLAND PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | INJECTABLE;INJECTION | EQ 1MG BASE/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25021-316 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | Sagent Pharmaceuticals | ANDA | Current |
| 43066-997 | Norepinephrine Bitartrate | norepinephrine bitartrate | Baxter Healthcare Corporation | ANDA | Current |
| 43066-997 | Norepinephrine Bitartrate | norepinephrine bitartrate | Baxter Healthcare Corporation | ANDA | Current |
| 68083-437 | Norepinephrine bitartrate | Norepinephrine bitartrate | Gland Pharma Limited | ANDA | Current |